• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Osteonecrosis of the jaw induced by immune checkpoint inhibitors: an urgent need for attention.

作者信息

Li Xinya, Song Zaiwei, Zhao Rongsheng

机构信息

Department of Pharmacy, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.

Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.

出版信息

J Transl Med. 2023 Sep 5;21(1):592. doi: 10.1186/s12967-023-04482-z.

DOI:10.1186/s12967-023-04482-z
PMID:37670367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10478485/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16b/10478485/8b596f31fb62/12967_2023_4482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16b/10478485/61acb63d7a0d/12967_2023_4482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16b/10478485/8b596f31fb62/12967_2023_4482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16b/10478485/61acb63d7a0d/12967_2023_4482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16b/10478485/8b596f31fb62/12967_2023_4482_Fig2_HTML.jpg

相似文献

1
Osteonecrosis of the jaw induced by immune checkpoint inhibitors: an urgent need for attention.免疫检查点抑制剂所致颌骨骨坏死：亟需关注
J Transl Med. 2023 Sep 5;21(1):592. doi: 10.1186/s12967-023-04482-z.
2
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.与非抗吸收药物相关的颌骨坏死：系统评价。
Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23.
3
Osteonecrosis of the jaw in a metastatic lung cancer patient with bone metastases undergoing pembrolizumab + denosumab combination therapy: Case report and literature review.骨转移肺癌患者行派姆单抗+地舒单抗联合治疗后发生下颌骨坏死：病例报告及文献复习。
Oral Oncol. 2020 Dec;111:104874. doi: 10.1016/j.oraloncology.2020.104874. Epub 2020 Jun 27.
4
Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals.芳香酶抑制剂相关的颌骨坏死：信号细化以识别假安全信号。
Int J Clin Pharm. 2020 Apr;42(2):721-727. doi: 10.1007/s11096-020-01018-z. Epub 2020 Apr 8.
5
The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw.抗血管生成疗法在颌骨坏死发展中的作用
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):547-53. doi: 10.1016/j.coms.2015.06.004.
6
Drug induced osteonecrosis of the jaw.药物性颌骨骨坏死。
Cancer Treat Rev. 2015 May;41(5):455-64. doi: 10.1016/j.ctrv.2015.04.007. Epub 2015 Apr 21.
7
Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors.肿瘤坏死因子 α 抑制剂治疗的炎症性肠病患者的颌骨坏死。
Int J Oral Maxillofac Surg. 2020 Mar;49(3):317-324. doi: 10.1016/j.ijom.2019.08.007. Epub 2019 Aug 27.
8
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.药物相关性颌骨坏死的诊断与分期
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18.
9
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.抗骨吸收（靶向骨）药物之外的颌骨骨坏死：肿瘤学的新视野
Expert Opin Drug Saf. 2016 Jul;15(7):925-35. doi: 10.1080/14740338.2016.1177021. Epub 2016 May 3.
10
Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw.己酮可可碱对药物相关性颌骨坏死的积极作用。
J Stomatol Oral Maxillofac Surg. 2020 Jun;121(3):264-267. doi: 10.1016/j.jormas.2019.12.003. Epub 2019 Dec 18.

引用本文的文献

1
Exploring the Impact of Novel Anti-Cancer Therapies on Jaw Osteonecrosis and Other Bones: A Comprehensive Review.探索新型抗癌疗法对颌骨坏死及其他骨骼的影响：一项综述
J Clin Med. 2024 Mar 25;13(7):1889. doi: 10.3390/jcm13071889.

本文引用的文献

1
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
2
Medication-Related Osteonecrosis of the Jaw with Spontaneous Hemimaxilla Exfoliation: Report of a Case in Metastatic Renal Cancer Patient under Multidrug Therapy.药物相关性颌骨坏死伴自发性半侧上颌骨脱落：一例接受多药治疗的转移性肾癌患者的病例报告
Case Rep Med. 2020 Oct 22;2020:8093293. doi: 10.1155/2020/8093293. eCollection 2020.
3
Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report.
抗 PD-1 免疫治疗引起的下颌骨坏死：病例报告。
Immunotherapy. 2020 Dec;12(17):1213-1219. doi: 10.2217/imt-2020-0108. Epub 2020 Sep 9.
4
Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.抗癌靶向治疗和免疫检查点抑制剂引起的口腔黏膜变化
Support Care Cancer. 2017 May;25(5):1713-1739. doi: 10.1007/s00520-017-3629-4. Epub 2017 Feb 22.
5
OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.OpenVigil美国食品药品监督管理局——美国药品不良事件药物警戒数据及新型临床应用检查
PLoS One. 2016 Jun 21;11(6):e0157753. doi: 10.1371/journal.pone.0157753. eCollection 2016.
6
Osteonecrosis of the jaw a new complication related to Ipilimumab.颌骨骨坏死——一种与伊匹单抗相关的新并发症。
Oral Oncol. 2015 Dec;51(12):e100-1. doi: 10.1016/j.oraloncology.2015.08.014. Epub 2015 Oct 5.
7
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.药物性颌骨坏死的发生率及其相关危险因素。
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
8
Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.转移性肾细胞癌患者接受舒尼替尼治疗后出现牙龈出血和颌骨坏死：2 例具有临床意义的病例报告。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Feb;113(2):234-8. doi: 10.1016/j.tripleo.2011.08.024. Epub 2012 Jan 20.
9
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.使用比例报告比（PRR）从自发药物不良反应报告中生成信号。
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6. doi: 10.1002/pds.677.
10
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.活化的T细胞通过骨保护素配体调节佐剂性关节炎中的骨质流失和关节破坏。
Nature. 1999 Nov 18;402(6759):304-9. doi: 10.1038/46303.